Calithera Biosciences, Inc. (CALA)
OTCMKTS: CALA · Delayed Price · USD
0.0500
+0.0300 (150.00%)
Apr 15, 2024, 3:42 PM EDT - Market closed
Calithera Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 25.45 | 59.54 | 107.15 | 60.44 | 51.06 | 48.48 | 10.6 | 6.11 | 101.97 | 33.82 | Upgrade
|
| Short-Term Investments | 0 | 0 | 8.01 | 96.92 | 85.1 | 115.32 | 41.18 | 63.82 | 0 | 0 | Upgrade
|
| Cash & Cash Equivalents | 25.45 | 59.54 | 115.15 | 157.36 | 136.15 | 186.15 | 51.78 | 71.93 | 101.97 | 33.82 | Upgrade
|
| Cash Growth | -57.25% | -48.30% | -26.82% | 15.58% | -26.86% | 259.50% | -28.01% | -29.46% | 201.51% | 1433.79% | Upgrade
|
| Receivables | 0 | 0 | 1.54 | 0.48 | 2 | 1.14 | 0 | 0 | 0 | 0 | Upgrade
|
| Inventory | 0 | 0 | -1.54 | -0.48 | -2 | -22.36 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Assets | 1.17 | 1.92 | 3.55 | 2.44 | 4.1 | 25.09 | 1.78 | 2.57 | 1.89 | 0.35 | Upgrade
|
| Total Current Assets | 26.62 | 61.45 | 118.7 | 159.8 | 140.25 | 167.67 | 53.56 | 72.5 | 103.86 | 34.17 | Upgrade
|
| Property, Plant & Equipment | 1.78 | 3.03 | 6.44 | 8.25 | 1.46 | 1.76 | 0.9 | 0.93 | 0.86 | 0.56 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 22.36 | 0 | 2 | 0 | 0 | Upgrade
|
| Other Long-Term Assets | 0.27 | 0.27 | 0.44 | 0.72 | 1.01 | 0.67 | 0.34 | 0.33 | 0.05 | 0.12 | Upgrade
|
| Total Long-Term Assets | 2.05 | 3.3 | 6.88 | 8.97 | 2.47 | 24.79 | 1.24 | 3.26 | 0.91 | 0.68 | Upgrade
|
| Total Assets | 28.68 | 64.76 | 125.59 | 168.77 | 142.73 | 192.46 | 54.8 | 75.75 | 104.77 | 34.84 | Upgrade
|
| Accounts Payable | 0.73 | 3.65 | 1.99 | 2.05 | 1.25 | 1.07 | 0.4 | 0.56 | 0.69 | 0.15 | Upgrade
|
| Deferred Revenue | 0 | 8.37 | 13.05 | 1.55 | 2.47 | 29.02 | 0 | 0 | 0 | 0 | Upgrade
|
| Current Debt | 1.53 | 1.37 | 1.9 | 1.48 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Liabilities | 5.13 | 0.61 | 1.45 | 14.55 | 11.17 | 8.94 | 4.06 | 3.27 | 3.43 | 1.19 | Upgrade
|
| Total Current Liabilities | 7.39 | 14.01 | 18.4 | 19.62 | 14.88 | 39.03 | 4.45 | 3.83 | 4.12 | 1.34 | Upgrade
|
| Long-Term Debt | 0.14 | 1.67 | 4.82 | 6.72 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Liabilities | 0.76 | 40.7 | 0 | 0 | 1.13 | 3.12 | 0.44 | 0.13 | 0.28 | 54.31 | Upgrade
|
| Total Long-Term Liabilities | 0.89 | 42.37 | 4.82 | 6.72 | 1.13 | 3.12 | 0.44 | 0.13 | 0.28 | 54.31 | Upgrade
|
| Total Liabilities | 8.28 | 56.37 | 23.22 | 26.34 | 16.01 | 42.15 | 4.89 | 3.96 | 4.4 | 55.66 | Upgrade
|
| Total Debt | 1.67 | 3.04 | 6.72 | 8.2 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Debt Growth | -45.20% | -54.75% | -18.03% | - | - | - | - | - | - | - | Upgrade
|
| Common Stock | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Retained Earnings | -512.62 | -491.33 | -376.24 | -286.1 | -196.17 | -150.33 | -122.5 | -84.5 | -51.85 | -30.14 | Upgrade
|
| Comprehensive Income | 0 | -40.7 | 0 | 0.04 | -0.11 | -0.27 | -0.01 | -0.07 | -1.23 | -0.87 | Upgrade
|
| Shareholders' Equity | 20.39 | -491.33 | -376.24 | -286.1 | -196.17 | 150.31 | 49.91 | 71.79 | -51.85 | -20.81 | Upgrade
|
| Total Liabilities and Equity | 28.68 | -434.95 | -353.02 | -259.76 | -180.16 | 192.46 | 54.8 | 75.75 | -47.45 | 34.84 | Upgrade
|
| Net Cash / Debt | 23.79 | 56.5 | 108.43 | 149.17 | 136.15 | 163.79 | 51.78 | 69.93 | 101.97 | 33.82 | Upgrade
|
| Net Cash / Debt Growth | -57.90% | -47.90% | -27.31% | 9.56% | -16.87% | 216.32% | -25.95% | -31.42% | 201.51% | 1433.79% | Upgrade
|
| Net Cash Per Share | 4.76 | 15.30 | 31.51 | 63.06 | 74.39 | 99.42 | 53.15 | 77.50 | 438.39 | 85.69 | Upgrade
|
| Working Capital | 19.23 | 47.45 | 100.3 | 140.17 | 125.37 | 128.64 | 49.11 | 68.66 | 99.74 | 32.83 | Upgrade
|
| Book Value Per Share | 4.08 | -133.04 | -109.34 | -120.94 | -107.19 | 91.23 | 51.22 | 79.57 | -222.93 | -52.73 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.